Skip to main content

Tonix Pharmaceuticals Holding Corp (TNXP) Stock

Tonix Pharmaceuticals Holding Corp Stock Details, Movements and Public Alerts

Stock Details

Tonix Pharmaceuticals Holding Corp (TNXP), a prominent company in the life sciences sector within the pharmaceutical preparations industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $44.72. Over the past 52 weeks, it has ranged between $6.76 and $72.00. This places the current price at 62.1% of its 52-week high and 561.5% above its 52-week low. Recent trading volume was recorded at 844,966. The 14-day Relative Strength Index (RSI) stands at 55.27, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $28.36 by 57.69%. Similarly, it is above its 200-day moving average of $21.87 by 104.48%. The MACD histogram is -0.63, indicating bearish momentum (MACD Line: 1.36, Signal Line: 1.98).

Market Cap

$256.69M

52-Week High

$72.00

-37.89% from high

52-Week Low

$6.76

+561.54% from low

Avg Daily Volume

1,336,013

100-day average

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

0.10

Below market average

PEG Ratio

0.00

Potentially undervalued

Price to Book

1.42

EV/EBITDA

0.94

EPS (TTM)

$356.28

Price to Sales

25.56

Beta

2.10

More volatile than market

How is TNXP valued relative to its earnings and growth?
Tonix Pharmaceuticals Holding Corp trades at a P/E ratio of 0.10, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong.0
What is TNXP's risk profile compared to the market?
With a beta of 2.10, Tonix Pharmaceuticals Holding Corp is significantly more volatile than the market. For every 10% market move, this stock tends to move 21% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 1.42 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-661.00%

Return on Equity

-91.40%

Return on Assets

-27.60%

Revenue Growth (YoY)

-2.10%

Earnings Growth (YoY)

0.00%

How profitable and efficient is TNXP's business model?
0 The operating margin of -661.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -91.40% and ROA at -27.60%, the company achieves moderate returns on invested capital.
What are TNXP's recent growth trends?
Tonix Pharmaceuticals Holding Corp's revenue declined by 2.10% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against PHARMACEUTICAL PREPARATIONS industry averages for proper context.

Company Size & Market

Shares Outstanding

7.36M

Book Value/Share

$26.23

Asset Type

Common Stock

What is TNXP's market capitalization and position?
Tonix Pharmaceuticals Holding Corp has a market capitalization of $256.69M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 7.36M shares outstanding, the company's ownership is relatively concentrated. As a participant in the PHARMACEUTICAL PREPARATIONS industry, it competes with other firms in this sector.
How does TNXP's price compare to its book value?
Tonix Pharmaceuticals Holding Corp's book value per share is $26.23, while the current stock price is $44.72, resulting in a price-to-book (P/B) ratio of 1.70. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$61.67

37.90% upside potential

Analyst Recommendations

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

How reliable are analyst predictions for TNXP?
1 analysts cover TNXP with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $61.67 implies 37.9% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on TNXP?
Current analyst recommendations:01 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Jul 1, 2025, 02:05 AM

Technical Indicators

RSI (14-day)

55.27

Neutral

50-Day Moving Average

$28.36

57.69% above MA-50

200-Day Moving Average

$21.87

104.48% above MA-200

MACD Line

1.36

MACD Signal

1.98

MACD Histogram

-0.63

Bearish

What does TNXP's RSI value tell investors?
The RSI (Relative Strength Index) for TNXP is currently 55.27, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret TNXP's MACD and moving average crossovers?
MACD analysis shows the MACD line at 1.36 below the signal line at 1.98, with histogram at -0.63. This bearish crossover indicates downward pressure. The 50-day MA ($28.36) is above the 200-day MA ($21.87), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Jul 1, 2025, 12:30 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for TNXP and get notified when the price changes.

Stay Ahead of the Market with Tonix Pharmaceuticals Holding Corp Alerts

Set up price alerts for Tonix Pharmaceuticals Holding Corp and get notified instantly when the price hits your target. Never miss an important price movement again.